Browsing by Author Ward, Robyn L

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 12 of 12
Issue DateTitleAuthor(s)Citation
2014Altered promoter nucleosome positioning is an early event in gene silencingBourke, Michael; Hawkins, Nicholas; Hesson, Luke B; Ng, Benedict; Nunez, Andrea C; Sloane, Mathew A; Srivastava, Sameer; Ward, Robyn L; Wong, Jason WH; Western Clinical School: Medicine (Westmead)Altered promoter nucleosome positioning is an early event in gene silencing, Epigenetics, vol.9, 10, 2014,pp 1422-1430
2015Can administrative data be used to measure chemotherapy side effects?Pearson, Sallie-Anne; Srasuebkul, Preeyaporn; Haas, M; Haywood, Philip; Pearce, Alison; Van Gool, Kees; Viney, Rosalie; Ward, Robyn L; Pharmacy; PharmacyCan administrative data be used to measure chemotherapy side effects?, Expert Review of Pharmacoeconomics and Outcomes Research, vol.15, 2, 2015,pp 215-222
2015Cost of cancer care for patients undergoing chemotherapy: The Elements of Cancer Care studyPearson, Sallie-Anne; Bastick, Patricia; Daniels, Benjamin; Haas, Marion; Haywood, Philip; Hou, Changhao; Laaksonen, Maarit A; Norman, Richard; Van Gool, Kees; Ward, Robyn L; PharmacyCost of cancer care for patients undergoing chemotherapy: The Elements of Cancer Care study, Asia-Pacific Journal of Clinical Oncology, vol.11, 2, 2015,pp 178-186
2017Exploring clinicians' attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancerChen, Yanni; Kirk, Judy; Goodwin, Annabel; Hiller, Janet; Kaur, Rajneesh; Macrae, Finlay; Meiser, Bettina; Mitchell, Gillian; Peate, Michelle; Trainer, Alison; Ward, Robyn L; Wong, Tim; Northern Clinical School: Kolling Institute; Western Clinical School: Westmead Institute for Medical ResExploring clinicians' attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer, Familial Cancer, vol.16, 1, 2017,pp 99-109
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2018Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Houssami, Nehmat; Kiely, Belinda Emma; Lord, Sarah (Sally); Daniels, Benjamin; Lu, Christine; Pearson, Sallie-Anne; Ward, Robyn L; School of Public Health: Public Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreLong-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016), Breast Cancer Research and Treatment, vol.171, 1, 2018,pp 151-159
2017Retrospective comparison of Australia's Pharmaceutical Benefits Scheme claims data with prescription data in HER2-positive early breast cancer patients, 2008-2012Pearson, Sallie-Anne; Daniels, Benjamin; Harris, Carole; Ward, Robyn L; PharmacyRetrospective comparison of Australia's Pharmaceutical Benefits Scheme claims data with prescription data in HER2-positive early breast cancer patients, 2008-2012, Public Health Research and Practice, vol.27, 5, 2017,pp 1-9